Syntekabio
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Expo Tower 1 1903 Expo-ro, Daejeon, Yuse...Phone Number
(408) 636-2122Website
www.syntekabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Syntekabio
Syntekabio is an AI and NGS-based drug development company, utilizing a genomic database and AI to predict and identify new molecular entities to develop new drug products. The company is headquartered in Daejeon, Rep. of Korea, with offices in Seoul, and Rockville, MD, USA.Explore more
Syntekabio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Syntekabio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Syntekabio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Syntekabio recently announced quarterly report
Product Launch: Get notified when Syntekabio launches new products
Check if Syntekabio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Syntekabio
Click to see if Syntekabio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Syntekabio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Syntekabio is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Syntekabio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Syntekabio
Compare insights from companies similar to Syntekabio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Syntekabio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Syntekabio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Syntekabio.
Syntekabio Tech Stack
A closer look at the technologies used by Syntekabio
See more technologies
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Events
Syntekabio News & Media
Syntekabio Publishes Peer-Reviewed Study in Molecules on LLM-Driven Small-Molecule Binding Prediction
NEW YORK, NY, UNITED STATES, December 3, 2025 /EINPresswire.com/ -- Syntekabio (KOSDAQ: 226330), a global leader in AI-powered drug discovery, is pleased to announce that its research manuscript, “Systematic Exploration of Small-Molecule Binding via a …Syntekabio Begins Full-Scale Operation of AI-Driven Asset Program
Syntekabio Launched AI Asset Programs to Identify Antibody and Small-molecule Drug Candidates NEW YORK, NY, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- AI drug discovery company Syntekabio (KOSDAQ: 226330) announced on October 14 that it has …MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241
Partnership Leverages Syntekabio's DeepMatcher® Platform to Expand the Therapeutic Potential of MetaVia's Oral GPR119 Agonist CAMBRIDGE, Mass., Aug. 4, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic...Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025
NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), a leading artificial intelligence (AI)-driven drug development company, is pleased to announce its participation in Biotech Showcase 2025, taking place January 13–15, 2025, in San Francisco.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Syntekabio
Sign Up For FreeTo access detailed company insights
Syntekabio is an AI and NGS-based drug development company, utilizing a genomic database and AI to predict and identify new molecular entities to develop new drug products. The company is headquartered in Daejeon, Rep. of Korea, with offices in Seoul, and Rockville, MD, USA.... Read More
